Gene-network inference by message passing

The inference of gene-regulatory processes from gene-expression data belongs to the major challenges of computational systems biology. Here we address the problem from a statistical-physics perspective and develop a message-passing algorithm which is able to infer sparse, directed and combinatorial regulatory mechanisms. Using the replica technique, the algorithmic performance can be characterized analytically for artificially generated data. The algorithm is applied to genome-wide expression data of baker's yeast under various environmental conditions. We find clear cases of combinatorial control, and enrichment in common functional annotations of regulated genes and their regulators.Comment: Proc. of International Workshop on Statistical-Mechanical Informatics 2007, Kyot

Gene-network inference by message passing

The inference of gene-regulatory processes from gene-expression data belongs to the major challenges of computational systems biology. Here we address the problem from a statistical-physics perspective and develop a message-passing algorithm which is able to infer sparse, directed and combinatorial regulatory mechanisms. Using the replica technique, the algorithmic performance can be characterized analytically for artificially generated data. The algorithm is applied to genome-wide expression data of baker's yeast under various environmental conditions. We find clear cases of combinatorial control, and enrichment in common functional annotations of regulated genes and their regulators.Comment: Proc. of International Workshop on Statistical-Mechanical Informatics 2007, Kyot

Computational Biomarker Discovery: From Systems Biology to Predictive and Personalized Medicine Applications

poster abstractWith the advent of Genome-based Medicine, there is an escalating need for discovering how the modifications of biological molecules, either individually or as an ensemble, can be uniquely associated with human physiological states. This knowledge could lead to breakthroughs in the development of clinical tests known as "biomarker tests" to assess disease risks, early onset, prognosis, and treatment outcome predictions. Therefore, development of molecular biomarkers is a key agenda in the next 5-10 years to take full advantage of the human genome to improve human well-beings. However, the complexity of human biological systems and imperfect instrumentations of high-throughput biological instruments/results have created significant hurdles in biomarker development. Only recently did computational methods become an important player of the research topic, which has seen conventional molecular biomarkers development both extremely long and cost-ineffective. At Indiana Center for Systems Biology and Personalized Medicine, we are developing several computational systems biology strategies to address these challenges. We will show examples of how we approach the problem using a variety of computational techniques, including data mining, algorithm development to take into account of biological contexts, biological knowledge integration, and information visualization. Finally, we outline how research in this direction to derive more robust molecular biomarkers may lead to predictive and personalized medicine. Indiana Center for Systems Biology and Personalized Medicine (CSBPM) was founded in 2007 as an IUPUI signature center by Dr. Jake Chen and his colleagues in the Indiana University School of Informatics, School of Medicine, and School of Science. CSBPM is the only research center in the State of Indiana with the primary goal of pursuing predictive and personalized medicine. CSBPM currently consists of eleven faculty members from the School of Medicine, School of Science, School of Engineering, School of Informatics, and Indiana University Simon Cancer Center. The primary mission of the center is to foster the development and use of systems biology and computational modeling techniques to address challenges in future genome-based medicine. The ultimate goal of the center is to shorten the discovery-to-practice gap between integrative ―Omics‖ biology studies—including genomics, transcriptomics, proteomics, and metabolomics—and predictive and personalized medicine applications

Educating the educators: Incorporating bioinformatics into biological science education in Malaysia

Bioinformatics can be defined as a fusion of computational and biological sciences. The urgency to process and analyse the deluge of data created by proteomics and genomics studies has caused bioinformatics to gain prominence and importance. However, its multidisciplinary nature has created a unique demand for specialist trained in both biology and computing. In this review, we described the components that constitute the bioinformatics field and distinctive education criteria that are required to produce individuals with bioinformatics training. This paper will also provide an introduction and overview of bioinformatics in Malaysia. The existing bioinformatics scenario in Malaysia was surveyed to gauge its advancement and to plan for future bioinformatics education strategies. For comparison, we surveyed methods and strategies used in education by other countries so that lessons can be learnt to further improve the implementation of bioinformatics in Malaysia. It is believed that accurate and sufficient steerage from the academia and industry will enable Malaysia to produce quality bioinformaticians in the future

XML in Motion from Genome to Drug

Information technology (IT) has emerged as a central to the solution of contemporary genomics and drug discovery problems. Researchers involved in genomics, proteomics, transcriptional profiling, high throughput structure determination, and in other sub-disciplines of bioinformatics have direct impact on this IT revolution. As the full genome sequences of many species, data from structural genomics, micro-arrays, and proteomics became available, integration of these data to a common platform require sophisticated bioinformatics tools. Organizing these data into knowledgeable databases and developing appropriate software tools for analyzing the same are going to be major challenges. XML (eXtensible Markup Language) forms the backbone of biological data representation and exchange over the internet, enabling researchers to aggregate data from various heterogeneous data resources. The present article covers a comprehensive idea of the integration of XML on particular type of biological databases mainly dealing with sequence-structure-function relationship and its application towards drug discovery. This e-medical science approach should be applied to other scientific domains and the latest trend in semantic web applications is also highlighted

Synthetic biology—putting engineering into biology

Synthetic biology is interpreted as the engineering-driven building of increasingly complex biological entities for novel applications. Encouraged by progress in the design of artificial gene networks, de novo DNA synthesis and protein engineering, we review the case for this emerging discipline. Key aspects of an engineering approach are purpose-orientation, deep insight into the underlying scientific principles, a hierarchy of abstraction including suitable interfaces between and within the levels of the hierarchy, standardization and the separation of design and fabrication. Synthetic biology investigates possibilities to implement these requirements into the process of engineering biological systems. This is illustrated on the DNA level by the implementation of engineering-inspired artificial operations such as toggle switching, oscillating or production of spatial patterns. On the protein level, the functionally self-contained domain structure of a number of proteins suggests possibilities for essentially Lego-like recombination which can be exploited for reprogramming DNA binding domain specificities or signaling pathways. Alternatively, computational design emerges to rationally reprogram enzyme function. Finally, the increasing facility of de novo DNA synthesis—synthetic biology’s system fabrication process—supplies the possibility to implement novel designs for ever more complex systems. Some of these elements have merged to realize the first tangible synthetic biology applications in the area of manufacturing of pharmaceutical compounds.